arrow
Back
M

Martin Hutchings

Rigshospitalet

55H-index
409Paper Count
1.5WCitation Count
Published Papers 79
Publication Date
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial
err2026-07-16
err0
errOAAI
errMartin Hutchings; Michael Dickinson; Giuseppe Gritti; Carmelo Carlo-Stella; William Townsend; Francesc Bosch; Nancy L. Bartlett; Guillaume Cartron; Herve Ghesquieres; Roch Houot; Harriet Walter; Fritz Offner; Natalie Dimier; Candice Jamois; Sylvia Herter; Abiraj Keelara; Sabine Wilson; Jeremy Gallien; Heather Hinton; Isabel Prieto Gonzalez-Albo; Koorosh Korfi; Georgios Kazantzidis; Marie-Hélène Wasmer; Katharina Lechner; Franck Morschhauser
errShare
errSave
Rituximab maintenance after first-line rituximab-bendamustine
err2026-05-14
err0
errOAAI
errChristian Brieghel; Mikkel Werling; Peter Brown; Martin Hutchings; Carsten Niemann
errShare
errSave
Glofitamab monotherapy in patients with Richter transformation: safety and efficacy from a phase 1 study
err2026-04-27
err0
errOAAI
errCarmelo Carlo-Stella; Martin Hutchings; Fritz Offner; Estefania Mulvihill; James Relf; Fabiola Bene Tchaleu; Linda Lundberg; Michael Dickinson
errShare
errSave
A real-world comparison of CD20xCD3 bispecific antibodies versus chemotherapy regimens in 3+line relapsed/refractory diffuse large B cell lymphoma
err2026-03-01
err0
PREAI
errKyvsgaard, Emil Ramso; Fuglkjaer, Alexander Djupnes; Al-Mashhadi, Ahmed Ludvigsen; Riley, Caroline Hasselbalch; Brown, Peter; Niemann, Carsten Utoft; Christensen, Jacob Haaber; Clausen, Michael Roost; Gronbaek, Kirsten; Hutchings, Martin; Larsen, Thomas Stauffer; El-Galaly, Tarec Christoffer; Husby, Simon
errShare
errSave
Efficacy and safety of epcoritamab in relapsed or refractory large B-cell lymphoma: 3-year update from the EPCORE NHL-1 trial
err2026-02-04
err0
errOAAI
errKarimi, Yasmin H.; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Farooq, Umar; Feldman, Tatyana; Ghesquieres, Herve; Jurczak, Wojciech; Linton, Kim M.; Phillips, Tycel; Vose, Julie M.; Kim, Won Seog; Jafarinasabian, Pegah; D'angelo Mansson, Barbara; Soong, David; Steele, Andrew J.; Li, Zhu; Eskelund, Christian W.; Hutchings, Martin; Thieblemont, Catherine
errShare
errSave
Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First-Line Chemotherapy in Patients With Lymphoma
err2025-11-04
err0
PREAI
errCharlotte Nørregaard Grønset; Mary Jarden; Jan Christensen; Casper Simonsen; Anders Tolver; Charlotte Suetta; Martin Hutchings
errShare
errSave
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma
errBlood
IF23.1
err2025-09-10
err0
errOAAI
errLorenzo Falchi; Anna Sureda; Sirpa Leppä; Joost S.P. Vermaat; Marcel Nijland; Jacob Haaber Christensen; Sven de Vos; Harald Holte; Reid W. Merryman; Pieternella J. Lugtenburg; Pau Abrisqueta; Kim M. Linton; Gauri Sunkersett; Daniela Hoehn; Ali Rana; Aqeel Abbas; Jennifer Marek; Yi Hao; Andrew J. Steele; Christopher Morehouse; Martin Hutchings; David Belada
errShare
errSave
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients
err2025-08-18
err0
errOAAI
errPaul J. Bröckelmann; Boris Böll; Daniel Molin; Gundolf Schneider; Sirpa Leppä; Julia Meissner; Peter Kamper; Martin Hutchings; Jacob H. Christensen; Ulf Schnetzke; Michael Fuchs; Janina Jablonski; Dennis A. Eichenauer; Bastian von Tresckow; Wolfram Klapper; Carsten Kobe; Peter Borchmann; Alexander Fosså
errShare
errSave
Working towards harmonization of clinical trial reporting in Hodgkin lymphoma
err2025-08-07
err0
errOAAI
errCarsten Kobe; Philippe Armand; Sven Borchmann; Graham P. Collins; Anne-Segolene Cottereau; Justin Ferdinandus; Alex F. Herrera; Davide Rossi; Wouter J. Plattel; Sally F. Barrington; Martin Hutchings
errShare
errSave
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma
err2025-05-27
err0
errOAAI
errLeo Meriranta; Rasmus Rask Kragh Jørgensen; Annika Pasanen; Arne Kolstad; Martin Hutchings; Carsten Utoft Niemann; Tarec Christoffer El-Galaly; Jon Riise; Jacob Haaber Christensen; Kristina Sonnevi; Lone Bredo Pedersen; Karin Fahl Wader; Ingrid Glimelius; Sirpa Leppä; Mats Jerkeman
errShare
errSave
NOTCH1 Mutations Are Associated With Therapy-Resistance in Patients With B-Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies
err2025-01-25
err1
PREAI
errKyvsgaard, ER; Grauslund, M; Sjo, L; Melchior, LC; Grantzau, TL; Gjerdrum, LMR; Trab, T; Andersen, LS; Gang, AO; Breinholt, M; Moller, MB; Christensen, JH; Larsen, TS; Clausen, MR; Riley, CH; Niemann, CU; Gronbaek, K; Hutchings, M; Husby, S
errShare
errSave
Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab inpatients with relapsed/refractory large B-cell lymphoma
err2024-11-28
err0
errOAAI
errFalchi, Lorenzo; Hutchings, Martin; Carlo-Stella, Carmelo; Morschhauser, Franck; Dickinson, Michael; Cartron, Guillaume; Khan, Cyrus; Tani, Monica; Martinez-Lopez, Joaquin; Bartlett, Nancy L.; Salar, Antonio; Brody, Joshua D.; Berthier, Aurelien; Kallemeijn, Martine; Relf, James; Tchaleu, Fabiola Bene; Lundberg, Linda; Bachy, Emmanuel
errShare
errSave
Impact of Rituximab Maintenance Added to Ibrutinib-Containing Regimens with and without ASCT in Younger, Previously Untreated MCL Patients: An Analysis of the Triangle Data Embedded in the Multiply Project
errBLOOD
IF23.1
err2024-11-05
err3
PREAI
errLadetto, Marco; Gutmair, Katja; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Stefani, Piero Maria; Horowitz, Netanel A.; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Dreyling, Martin; Hoster, Eva
errShare
errSave
Role of Autologous Stem Cell Transplantation in the Context of Ibrutinib-Containing First-Line Treatment in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errDreyling, Martin; Doorduijn, Jeanette K.; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke K. J.; Donnarumma, Daniela; Shpilberg, Ofer; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Pott, Christiane; Klapper, Wolfram; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco; Hoster, Eva
errShare
errSave
Risk of cardiovascular disease in Hodgkin lymphoma patients
err2024-10-28
err0
PREAI
errGodtfredsen, S. J.; Yonis, H.; Baech, J.; Al-Hussainy, N. R.; Riddersholm, S. J.; Christensen, J. Haaber; Hutchings, M.; Dahl-Sorensen, R. B.; Kamper, P.; Dietrich, C. E.; Andersen, M. P.; Torp-Pedersen, C.; Sogaard, P.; El-Galaly, T. C.; Kragholm, K. H.
errShare
errSave
Concordance between late effects reported by physicians and patients in a cohort of long-term Hodgkin lymphoma survivors: an analysis of data from nine consecutive EORTC-LYSA trials
err2024-10-18
err0
errOAAI
errJuul, Sidsel J.; Rossetti, Sara; Aleman, Berthe M. P.; van Leeuwen, Flora E.; van der Kaaij, Marleen A. E.; Giusti, Francesco; Meijnders, Paul; Raemaekers, John M. M.; Kluin-Nelemans, Hanneke C.; Spina, Michele; Krzisch, Daphne; Bigenwald, Camille; Stamatoullas, Aspasia; Andre, Marc; Plattel, Wouter J.; Hutchings, Martin; Maraldo, Maja V.
errShare
errSave
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
errLEUKEMIA
IF13.4
err2024-09-25
err0
errOAAI
errThieblemont, Catherine; Karimi, Yasmin H.; Ghesquieres, Herve; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Jurczak, Wojciech; Do, Young Rok; Gasiorowski, Robin; Lewis, David John; Kim, Tae Min; van der Poel, Marjolein; Poon, Michelle Limei; Feldman, Tatyana; Linton, Kim M.; Sureda, Anna; Hutchings, Martin; Dinh, Minh H.; Kilavuz, Nurgul; Soong, David; Mark, Thomas; Sacchi, Mariana; Phillips, Tycel; Lugtenburg, Pieternella J.
errShare
errSave
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
err2024-08-01
err8
PREAI
errLinton, Kim M.; Vitolo, Umberto; Jurczak, Wojciech; Lugtenburg, Pieternella J.; Gyan, Emmanuel; Sureda, Anna; Christensen, Jacob Haaber; Hess, Brian; Tilly, Herve; Cordoba, Raul; Lewis, David John; Okada, Craig; Hutchings, Martin; Clausen, Michael Roost; Sancho, Juan-Manuel; Cochrane, Tara; Leppa, Sirpa; Chamuleau, Martine E. D.; Gernhardt, Diana; Altintas, Isil; Liu, Yan; Ahmadi, Tahamtan; Dinh, Minh H.; Hoehn, Daniela; Favaro, Elena; Elliott, Brian; Thieblemont, Catherine; Vose, Julie M.
errShare
errSave
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
errLANCET
IF88.5
err2024-05-01
err13
errOAAI
errDreyling, Martin; Doorduijn, Jeanette; Gine, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; da Silva, Maria Gomes; Leppa, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron; Celli, Melania; Hess, Georg; Arcaini, Luca; Visco, Carlo; van Meerten, Tom; Wirths, Stefan; Zinzani, Pier Luigi; Novak, Urban; Herhaus, Peter; Benedetti, Fabio; Sonnevi, Kristina; Hanoun, Christine; Haenel, Matthias; Dierlamm, Judith; Pott, Christiane; Klapper, Wolfram; Goezel, Doendue; Schmidt, Christian; Unterhalt, Michael; Ladetto, Marco; Hoster, Eva
errShare
errSave